CAMP4 Therapeutics Corp. (CAMP)
5.78
+1.18
(+25.65%)
USD |
NASDAQ |
Dec 10, 16:00
5.51
-0.27
(-4.67%)
After-Hours: 16:36
CAMP4 Therapeutics Shareholders Equity (Quarterly): 58.67M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| TransMedics Group, Inc. | 355.20M |
| Neumora Therapeutics, Inc. | 132.16M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.40M |
| Total Liabilities (Quarterly) | 27.73M |
| Debt to Equity Ratio | 0.1082 |
| Current Ratio | 9.833 |
| Net Debt Paydown Yield | -0.90% |